Popular Articles
Cellulite Cream

New Gene Discovery Links Obesity To The Brain
A variation in a gene that is active in the central nervous system is associated with increased risk for obesity, according to an international study in which Albert Einstein College of Medicine of Yeshiva University played a major role. The research adds to evidence that genes influence appetite and that the brain plays a key role in obesity.
generic viagra online
Being Overweight With Heart Risk In Mid Life Followed By Weight Loss Linked To More Illness And Higher Risk Of Death Later
Researchers in Finland who tracked the health of over 1,000 men from middle age into old age found that being overweight and having high risk
News of the day
SNM's Clinical Trials Network Expands European Membership Of PET Biomarker Manufacturers
SNM"s Clinical Trials Network have announced that several leading commercial providers of PET radiopharmaceuticals in Europe have registered their manufacturing sites with the network. SNM"s Clinical Trials Network is an initiative designed to address the need for streamlined drug discovery through the integration of imaging biomarkers into multi-center clinical trials.
Medical Devices

Science Magazine Spotlights 20 Years Of CF Research

An article in Science magazine this month highlights several promising new CF therapies, including VX-770 and VX-809 developed by Vertex Pharmaceuticals, as part of a look back at key moments in CF research since the discovery of the CF gene 20 years ago. The article notes the CF Foundation"s role in scientific discoveries: "The CF Foundation had been instrumental in funding the gene hunt and subsequent CF research, raising and investing tens of millions of dollars." In the piece, Francis Collins, former director of the National Human Genome Research Institute and co-discoverer of the CF gene, says the research community was initially skeptical about the Foundation"s focus on funding drug research to find a cure: "A lot of people thought that [CFF president] Bob Beall was going far out on a limb to put a lot of money into a strategy that was clearly risky." But now, following the Foundation"s investment of more than $75 million to develop VX-770 and VX-809, the "ò€¦two Vertex drugs are taking the CF world by storm." Cystic Fibrosis Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):